INKT
#4119
MiNK Therapeutics, Inc. - Common Stock
11.0 0 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.68%
Monthly Change
-13.32%
6 month change
-4.26%
Year Change
0.00%
Previous Close
11.4 2
Open
11.5 6
Low
10.9 6
High
11.5 6
Financials
- Market Capitalization 56.13 M
- Employee 15
- Founded 2017
- CEO N/A
- Website www.minktherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG012J84VS3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.81
Price to sales ratio
264.17
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4114 |  PDSB PDS Biotechnology Corporation - Common Stock | 1.02 USD | -4.67% | +43.66% | +251.72% | +2.00% | 57.09 M USD | ||
| 4116 |  OABIW OmniAb, Inc. - Warrant | 0.3900 USD | 0.00% | 0.00% | +6.12% | +160.00% | 56.70 M USD | ||
| 4120 |  GUTS Fractyl Health, Inc. - Common Stock | 4.23 USD | -6.42% | +861.36% | +531.34% | +200.00% | 56.11 M USD | ||
| 4125 |  ATHE Alterity Therapeutics Limited - American Depositary Shares | 3.07 USD | -7.53% | -9.44% | -31.17% | -27.59% | 55.65 M USD |
Frequently asked questions about MiNK Therapeutics, Inc. Common Stock
What is the MiNK Therapeutics, Inc. Common Stock stock price today?
The current price of MiNK Therapeutics, Inc. Common Stock (INKT) is 11.00. Over the past 24 hours, the stock has changed by -3.68%. Follow the INKT chart for real-time price dynamics.
What is the stock ticker of MiNK Therapeutics, Inc. Common Stock?
MiNK Therapeutics, Inc. Common Stock trades under the ticker INKT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MiNK Therapeutics, Inc. Common Stock stock going up?
INKT has changed by -12.35% over the last week, -13.32% over the last month, and 0.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of MiNK Therapeutics, Inc. Common Stock?
MiNK Therapeutics, Inc. Common Stock currently has a market capitalization of 56.13 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were MiNK Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, MiNK Therapeutics, Inc. Common Stock reported earnings of -0.62 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was MiNK Therapeutics, Inc. Common Stock revenue for the last quarter?
MiNK Therapeutics, Inc. Common Stock reported quarterly revenue of 72.88 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was MiNK Therapeutics, Inc. Common Stock net income for the last quarter?
MiNK Therapeutics, Inc. Common Stock reported net income of -3.13 M for the last quarter. The previous quarter showed -2.74 M, which means net income changed by -14.07%.
How many employees does MiNK Therapeutics, Inc. Common Stock have?
As of the latest available data, MiNK Therapeutics, Inc. Common Stock has 15 employees. Workforce size can provide additional context about the company's scale and operations.
What is MiNK Therapeutics, Inc. Common Stock EBITDA?
MiNK Therapeutics, Inc. Common Stock EBITDA is -1.22 M, and its EBITDA margin is -1 674.96%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy MiNK Therapeutics, Inc. Common Stock stock?
You can buy MiNK Therapeutics, Inc. Common Stock (INKT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MiNK Therapeutics, Inc. Common Stock stock?
Investing in MiNK Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INKT chart and related analysis on metatrader.com as part of your research.